FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4308133710> ?p ?o ?g. }

• W4308133710 endingPage "A644" @default.
• W4308133710 startingPage "A644" @default.
• W4308133710 abstract "Abstract Background Achondroplasia (ACH) is the most common short-limbed skeletal dysplasia, affecting between 1 in 15,000 to 1 in 30,000 live births. People with ACH are at risk for several significant co-morbidities, including foramen magnum stenosis, obstructive sleep apnea, chronic otitis media with conductive hearing loss, spinal stenosis, and a propensity towards obesity. PROPEL is a prospective, non-interventional study designed to examine baseline growth parameters and health status in children being assessed for potential enrollment into interventional studies with infigratinib, an oral FGFR1–3 inhibitor in development as a therapeutic option for ACH. Here we describe the medical complications reported as medical history in the PROPEL study. Methods Children with ACH between the ages of 2.5 and 10 years are eligible for enrollment in PROPEL and are evaluated at screening/baseline, month 3, month 6, and every 6 months thereafter. Medical history collected at screening/baseline is summarized using system organ class and preferred terms. Results A total of 86 children with ACH (60% female, mean±SD age 6.1±2.5 years) have been enrolled to date at 19 sites in Europe, Australia and North America. Fifty-eight children had undergone surgical and medical procedures with a mean of 2.9 procedures per child (1–11 surgeries/subject). The most common procedures were pressure-equalizing ear tube insertion, adenoidectomy and tonsillectomy. Twenty-one (24%) children had undergone at least 1 surgery (1–5 surgeries/child) for spine or cranial decompression. History of infections and respiratory disorders were reported in 46 (53%) and 40 (47%) children, respectively, the most common being ear infections and obstructive sleep apnea. Musculoskeletal disorders were described in 33 (38%) children, with kyphosis being the most common. Hydrocephalus was reported in 2 children, while 4 had ventriculomegaly without intracranial hypertension. Congenital cardiovascular abnormalities were found in 4 children, 2 of whom presented with patent ductus arteriosus and 2 had patent foramen ovale. A comprehensive summary of medical histories will be presented at the conference. Conclusions The PROPEL study has a planned total enrollment of 200 children and seeks to contribute to the deeper understanding of the natural history of ACH. Data described here highlight the significant complications and high number of interventions that children with ACH undergo throughout infancy and childhood. This stresses the importance of expert management of this complex condition. Presentation: Monday, June 13, 2022 12:30 p.m. - 2:30 p.m., Monday, June 13, 2022 1:05 p.m. - 1:10 p.m." @default.
• W4308133710 created "2022-11-08" @default.
• W4308133710 creator A5000857707 @default.
• W4308133710 creator A5000891412 @default.
• W4308133710 creator A5001570533 @default.
• W4308133710 creator A5001767521 @default.
• W4308133710 creator A5004969502 @default.
• W4308133710 creator A5006532808 @default.
• W4308133710 creator A5006745801 @default.
• W4308133710 creator A5008365701 @default.
• W4308133710 creator A5025914068 @default.
• W4308133710 creator A5028724151 @default.
• W4308133710 creator A5033079105 @default.
• W4308133710 creator A5040237112 @default.
• W4308133710 creator A5041349811 @default.
• W4308133710 creator A5042446335 @default.
• W4308133710 creator A5042951745 @default.
• W4308133710 creator A5049896329 @default.
• W4308133710 creator A5049904372 @default.
• W4308133710 creator A5061306814 @default.
• W4308133710 creator A5068575502 @default.
• W4308133710 creator A5069130924 @default.
• W4308133710 creator A5077589167 @default.
• W4308133710 creator A5078684328 @default.
• W4308133710 creator A5084662708 @default.
• W4308133710 date "2022-11-01" @default.
• W4308133710 modified "2023-09-27" @default.
• W4308133710 title "RF26 | PMON326 Medical History of Children Enrolled in PROPEL: A Prospective Clinical Assessment Study in Children with Achondroplasia" @default.
• W4308133710 doi "https://doi.org/10.1210/jendso/bvac150.1332" @default.
• W4308133710 hasPublicationYear "2022" @default.
• W4308133710 type Work @default.
• W4308133710 citedByCount "0" @default.
• W4308133710 crossrefType "journal-article" @default.
• W4308133710 hasAuthorship W4308133710A5000857707 @default.
• W4308133710 hasAuthorship W4308133710A5000891412 @default.
• W4308133710 hasAuthorship W4308133710A5001570533 @default.
• W4308133710 hasAuthorship W4308133710A5001767521 @default.
• W4308133710 hasAuthorship W4308133710A5004969502 @default.
• W4308133710 hasAuthorship W4308133710A5006532808 @default.
• W4308133710 hasAuthorship W4308133710A5006745801 @default.
• W4308133710 hasAuthorship W4308133710A5008365701 @default.
• W4308133710 hasAuthorship W4308133710A5025914068 @default.
• W4308133710 hasAuthorship W4308133710A5028724151 @default.
• W4308133710 hasAuthorship W4308133710A5033079105 @default.
• W4308133710 hasAuthorship W4308133710A5040237112 @default.
• W4308133710 hasAuthorship W4308133710A5041349811 @default.
• W4308133710 hasAuthorship W4308133710A5042446335 @default.
• W4308133710 hasAuthorship W4308133710A5042951745 @default.
• W4308133710 hasAuthorship W4308133710A5049896329 @default.
• W4308133710 hasAuthorship W4308133710A5049904372 @default.
• W4308133710 hasAuthorship W4308133710A5061306814 @default.
• W4308133710 hasAuthorship W4308133710A5068575502 @default.
• W4308133710 hasAuthorship W4308133710A5069130924 @default.
• W4308133710 hasAuthorship W4308133710A5077589167 @default.
• W4308133710 hasAuthorship W4308133710A5078684328 @default.
• W4308133710 hasAuthorship W4308133710A5084662708 @default.
• W4308133710 hasBestOaLocation W43081337101 @default.
• W4308133710 hasConcept C108516343 @default.
• W4308133710 hasConcept C126322002 @default.
• W4308133710 hasConcept C141071460 @default.
• W4308133710 hasConcept C187212893 @default.
• W4308133710 hasConcept C188816634 @default.
• W4308133710 hasConcept C206179267 @default.
• W4308133710 hasConcept C2776006263 @default.
• W4308133710 hasConcept C2776408402 @default.
• W4308133710 hasConcept C2776439223 @default.
• W4308133710 hasConcept C2777346780 @default.
• W4308133710 hasConcept C2777935920 @default.
• W4308133710 hasConcept C2779073326 @default.
• W4308133710 hasConcept C2780472190 @default.
• W4308133710 hasConcept C2781179581 @default.
• W4308133710 hasConcept C71924100 @default.
• W4308133710 hasConceptScore W4308133710C108516343 @default.
• W4308133710 hasConceptScore W4308133710C126322002 @default.
• W4308133710 hasConceptScore W4308133710C141071460 @default.
• W4308133710 hasConceptScore W4308133710C187212893 @default.
• W4308133710 hasConceptScore W4308133710C188816634 @default.
• W4308133710 hasConceptScore W4308133710C206179267 @default.
• W4308133710 hasConceptScore W4308133710C2776006263 @default.
• W4308133710 hasConceptScore W4308133710C2776408402 @default.
• W4308133710 hasConceptScore W4308133710C2776439223 @default.
• W4308133710 hasConceptScore W4308133710C2777346780 @default.
• W4308133710 hasConceptScore W4308133710C2777935920 @default.
• W4308133710 hasConceptScore W4308133710C2779073326 @default.
• W4308133710 hasConceptScore W4308133710C2780472190 @default.
• W4308133710 hasConceptScore W4308133710C2781179581 @default.
• W4308133710 hasConceptScore W4308133710C71924100 @default.
• W4308133710 hasIssue "Supplement_1" @default.
• W4308133710 hasLocation W43081337101 @default.
• W4308133710 hasLocation W43081337102 @default.
• W4308133710 hasOpenAccess W4308133710 @default.
• W4308133710 hasPrimaryLocation W43081337101 @default.
• W4308133710 hasRelatedWork W1940756633 @default.
• W4308133710 hasRelatedWork W1988111799 @default.
• W4308133710 hasRelatedWork W2000080275 @default.
• W4308133710 hasRelatedWork W2014681440 @default.
• W4308133710 hasRelatedWork W2091195090 @default.
• W4308133710 hasRelatedWork W2406280347 @default.

• next